PAINCEPTOR PHARMA
PainCeptor Pharma is a pharmaceutical company developing next generation therapeutic drugs for the treatment of chronic and acute pain. PainCeptor's therapeutic programs are concentrated on some of the most promising, novel, yet scientifically validated therapeutic targets within the PNS (peripheral nervous system). By focusing on modulating target receptors in the PNS, PainCeptor expects to enhance the efficacy and avoid the many detrimental side effects associated with today's pain drugs which act primarily in the CNS (central nervous system). PainCeptor's development pipeline includes two lead antagonist programs, targeting NGF/p75-TrkA and ASIC1a, and a third antagonist program targeting ASIC3.
PAINCEPTOR PHARMA
Industry:
Medical Pharmaceutical Therapeutics
Founded:
2004-01-01
Address:
Saint-laurent, Manitoba, Canada
Country:
Canada
Website Url:
http://www.painceptor.com
Total Employee:
1+
Status:
Active
Total Funding:
37.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Pound Sterling Japanese Yen Baidu Analytics
Similar Organizations
CorneaCare
Personalized dry eye treatment delivered and monitored.
Investors List
Lothian Partners
Lothian Partners investment in Series B - PainCeptor Pharma
Desjardins Venture Capital
Desjardins Venture Capital investment in Series B - PainCeptor Pharma
Business Development Bank of Canada
Business Development Bank of Canada investment in Series B - PainCeptor Pharma
CDP Capital Technology Ventures
CDP Capital Technology Ventures investment in Series B - PainCeptor Pharma
CDP Capital Technology Ventures
CDP Capital Technology Ventures investment in Series A - PainCeptor Pharma
More informations about "PainCeptor Pharma"
PainCeptor Pharma - Crunchbase Company Profile & Funding
PainCeptor Pharma is a pharmaceutical company developing next generation. therapeutic drugs for the treatment of chronic and acute pain. PainCeptor's. therapeutic programs are …See details»
PainCeptor Pharma - Wikiwand
PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system on nociceptors to treat pain. [3] The company was …See details»
PainCeptor - LinkedIn
PainCeptor Pharma Corporation is a Canadian-based, private biopharmaceutical company focused on the development of safe, effective and peripherally-active pharmaceuticals for the …See details»
PainCeptor Pharma - bionity.com
PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system to treat pain. The company's strategic focus on peripheral …See details»
Painceptor Pharma Corp - Company Profile and News
Painceptor Pharma Corporation was founded in 2004. The company's line of business includes providing commercial physical and biological research and development. ...See details»
PainCeptor Pharma Corp. - BioPharmaLink
Jan 13, 2005 PainCeptor Pharma Corp.: Founded in 2004, PainCeptor is focused on the development of novel analgesics for the treatment of moderate to severe chronic pain. …See details»
PainCeptor Pharma - Crunchbase
PainCeptor Pharma Inc., a Montreal-based drug company focused on the treatment of chronic and acute pain.See details»
PainCeptor Pharma - PE Hub
Mar 7, 2007 PainCeptor Pharma Inc., a Montreal-based drug company focused on the treatment of chronic and acute pain, has raised Cdn$24.4 million in Series B funding.Participants …See details»
Painceptor Pharma Corp - Company Profile & Staff Directory
PainCeptor Pharma Corporation is a Canadian-based, private biopharmaceutical company focused on the development of safe, effective and peripherally-active pharmaceuticals for the …See details»
PainCeptor Pharma - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 7, 2007: Series B - …See details»
Novel treatment of acute and chronic pain - McGill University
Antalium Inc. and Neuroceptor Inc., two spin-off companies of McGill and Queen's Universities respectively, have merged to form a new leading-edge biopharmaceutical company called …See details»
Painceptor Pharma Corp. - VentureRadar
Painceptor Pharma Corp. VentureRadar profile. Find out more about Painceptor Pharma Corp. including the VentureRadar Innovation and Growth scores, Similar Companies and more. ...See details»
PainCeptor Pharma - chemeurope.com
PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system to treat pain. The company's strategic focus on peripheral …See details»
PainCeptor Pharma Corp.
Sep 1, 2005 The calamitous demise of Vioxx and Celebrex has reinforced the terrific challenges facing companies that hope to develop novel therapies for pain. PainCeptor Pharma Corp. …See details»
OBIO Announces new Chair of the Board of Directors, Dr. Maura …
Mar 4, 2021 “As a thought leading organization, OBIO’s work is truly building the health science industry and it is my privilege to be a part of OBIO’s efforts to support technology …See details»
Recently Formed By Merger, PainCeptor Nets C$23 Million
Mar 23, 2004 Operations are well under way at PainCeptor Pharma Corp., a company just formed in a merger, as it concluded a Series A round of financing and secured its first …See details»
PainCeptor Pharma - Tech Stack, Apps, Patents & Trademarks
PainCeptor Pharma Inc., a Montreal-based drug company focused on the treatment of chronic and acute pain.See details»
PPC-5650 - Drug Targets, Indications, Patents - Synapse - Patsnap
PPC-5650: a Acid-sensing (proton-gated) ion channels (ASICs) inhibitors Drug, Initially developed by PainCeptor Pharma, Now, its global highest R&D status is Discontinued, Mechanism: Acid …See details»
PainCeptor Pharma announces positive clinical results that validate ...
Sep 15, 2008 PainCeptor Pharma announces positive clinical results that validate ASICs as novel targets for human pain 15-Sep-2008 - Canada PainCeptor Pharma announced that PPC …See details»